Targeted immunotherapies for Graves’ thyroidal & orbital diseases
BackgroundGraves’ hyperthyroidism and its associated Graves’ orbitopathy are common autoimmune disorders associated with significant adverse health impact.
Alan Chun Hong Lee, George J. Kahaly
doaj +1 more source
Sinonasal abnormalities in patients with graves' orbitopathy [PDF]
Zachary M. Soler+4 more
openalex +1 more source
Graves' Orbitopathy A multidisciplinary approach – questions and answers 2nd, revised edition (Wilmar M. Wiersinga and George J. Kahaly (Editors)) [PDF]
Henri Wallaschofski
openalex +1 more source
Serum BAFF Concentrations in Patients with Graves' Disease and Orbitopathy before and after Immunosuppressive Therapy [PDF]
Guia Vannucchi+11 more
openalex +1 more source
Possible Targets for Nonimmunosuppressive Therapy of Graves' Orbitopathy [PDF]
Lei Zhang+7 more
openalex +1 more source
Diagnosis of Graves' Orbitopathy (DiaGO): Results of a Pilot Study to Assess the Utility of an Office Tool for Practicing Endocrinologists [PDF]
Anna L. Mitchell+14 more
openalex +1 more source
There is a detectable immune activity in the orbits of all patients diagnosed with Graves' disease regardless of later development of Graves' orbitopathy [PDF]
Eszter Berta+8 more
openalex +1 more source
MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves’ orbitopathy – lessons from randomized control trials [PDF]
Marius N. Stan, Mario Salvi
openalex +1 more source
Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen [PDF]
Utta Berchner‐Pfannschmidt+9 more
openalex +1 more source